Next Article in Journal
Partial Characterization, the Immune Modulation and Anticancer Activities of Sulfated Polysaccharides from Filamentous Microalgae Tribonema sp.
Previous Article in Journal
Nutritional Composition, Anti-Diabetic Properties and Identification of Active Compounds Using UHPLC-ESI-Orbitrap-MS/MS in Mangifera odorata L. Peel and Seed Kernel
Previous Article in Special Issue
Solvents to Fragments to Drugs: MD Applications in Drug Design
Open AccessEditorial

Molecular Modeling in Drug Design

1
Heidelberg Institute for Theoretical Studies (HITS), Schloss-Wolfsbrunnenweg 35, 69118 Heidelberg, Germany
2
Zentrum für Molekulare Biologie der Universität Heidelberg (ZMBH), DKFZ-ZMBH Alliance, Im Neuenheimer Feld 282, and Interdisciplinary Center for Scientific Computing (IWR), Im Neuenheimer Feld 205, 69120 Heidelberg, Germany
3
Pharmaceutical Sciences Laboratory and Structural Bioinformatics Laboratory, Faculty of Science and Engineering, Åbo Akademi University, Biocity, Tykistökatu 6 A, FI 20520 Turku, Finland
*
Authors to whom correspondence should be addressed.
Molecules 2019, 24(2), 321; https://doi.org/10.3390/molecules24020321
Received: 14 January 2019 / Accepted: 15 January 2019 / Published: 17 January 2019
(This article belongs to the Special Issue Molecular Modeling in Drug Design)
Note: In lieu of an abstract, this is an excerpt from the first page.

This Special Issue contains thirteen articles that provide a vivid snapshot of the state-of-the-art of molecular modeling in drug design, illustrating recent advances and critically discussing important challenges [...] View Full-Text
MDPI and ACS Style

Wade, R.C.; Salo-Ahen, O.M.H. Molecular Modeling in Drug Design. Molecules 2019, 24, 321.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop